Further research is still required to examine whether other miRNAs or signaling pathways can regulate FOXO1 in prostate cancer, because we could not exclude that there might be other microRNAs, not found yet, to play an important role in regulating FOXO1 in prostate cancer, and whether miR-370 can target other members of the FOXO family. This evidence concerns the gene FOXO1 and prostate carcinoma.